<?xml version='1.0' encoding='UTF-8'?><codeBook xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd" version="2.5"><docDscr><citation><titlStmt><titl>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</titl><IDNo agency="DOI">doi:10.7939/DVN/10901</IDNo></titlStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><distDate>2016-10-21</distDate></distStmt><verStmt source="DVN"><version date="2017-05-26" type="RELEASED">1</version></verStmt><biblCit>Huang, Vivian; Madsen, Karen; Fedorak, Richard; Elahi, Shokrollah; Dieleman, Levinus; Wine, Eytan; Agrawal, Ambika, 2016, "Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation", https://doi.org/10.7939/DVN/10901, UAL Dataverse, V1</biblCit></citation></docDscr><stdyDscr><citation><titlStmt><titl>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</titl><IDNo agency="DOI">doi:10.7939/DVN/10901</IDNo></titlStmt><rspStmt><AuthEnty affiliation="University of Alberta">Huang, Vivian</AuthEnty><AuthEnty affiliation="University of Alberta">Madsen, Karen</AuthEnty><AuthEnty affiliation="University of Alberta">Fedorak, Richard</AuthEnty><AuthEnty affiliation="University of Alberta">Elahi, Shokrollah</AuthEnty><AuthEnty affiliation="University of Alberta">Dieleman, Levinus</AuthEnty><AuthEnty affiliation="University of Alberta">Wine, Eytan</AuthEnty><AuthEnty affiliation="University of Alberta">Agrawal, Ambika</AuthEnty></rspStmt><prodStmt><producer affiliation="University of Alberta" URI="http://pregnancy.ibdclinic.ca/">Preconception and Pregnancy in Inflammatory Bowel Disease Clinical Research Program</producer><prodDate>2015</prodDate><prodPlac>Edmonton, Alberta</prodPlac><software>Microsoft Excel</software><software version="23">SPSS</software></prodStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><contact affiliation="University of Alberta" email="pregibd@ualberta.ca">Huang, Vivian</contact></distStmt></citation><stdyInfo><subject><keyword>Medicine, Health and Life Sciences</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">Crohn's disease</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">pregnancy</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">ulcerative colitis</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">cohort studies</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">infant</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">breast milk</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">microbiota</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">immunology</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">inflammatory bowel diseases</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">breast feeding</keyword></subject><abstract>The objective of the study is to compare the intestinal inflammatory response markers of infants born to healthy mothers versus IBD mothers. As well, the fecal microbiome of infants who are breast fed by healthy mothers versus IBD mothers, and  the immunoactive components of breast milk from healthy mothers versus IBD mothers, will be compared.</abstract><sumDscr><timePrd cycle="P1" event="start" date="2015">2015</timePrd><timePrd cycle="P1" event="end" date="2017">2017</timePrd><collDate cycle="P1" event="start" date="2015-06">2015-06</collDate><collDate cycle="P1" event="end" date="2017">2017</collDate><dataKind>Clinical data; Biosamples; Questionnaire data</dataKind><nation>Canada</nation><geogCover>Edmonton</geogCover><geogCover>Alberta</geogCover><anlyUnit>Maternal/infant child dyad</anlyUnit><universe>Mother/infant pairs with mothers with IBD (cases) and healthy mothers (controls) and their infants.</universe></sumDscr></stdyInfo><method><dataColl><frequenc>Data was collected within 48 hours of delivery and at 3 months, 6 months, and 12 months post-delivery.</frequenc><sampProc>The target number of study participants is 60.</sampProc><targetSampleSize><sampleSize>60</sampleSize></targetSampleSize><sources/><collMode>Self-administered questionnaire: Paper; Physical measurements and tests</collMode><collSitu>Maternal breast milk and infant stool samples were collected at each time point. Stool was analysed for microbiome (diversity, communities), sIgA, FCP, cytokine levels. Breast milk was analysed for microbiome, sIgA, calprotectin, cytokines, protein and fat content, (oligosaccharides), in vitro functional studies on colonic cells. Questionnaires include questions about the mother's medication, nutritional supplementation, and questions about infant diet, developmental milestones, etc.</collSitu></dataColl><anlyInfo/></method><dataAccs><setAvail><accsPlac>CEGIIR (Centre of Excellence for Gastrointestinal Inflammation and Immunity Research) www.cegiir.med.ualberta.ca</accsPlac><avlStatus>Data is not available because the study is still recruiting.</avlStatus></setAvail><useStmt><conditions>Access to deidentified data may be permitted for external researchers, with limitations. Only researchers with REB-approved projects may be permitted access to the deidentified data. A basic data sharing agreement form is required (ie. Agree to not attempt to re-identify the records so as to relate the information on the file to a particular person). The data producer determines access on a case-by-case basis. Contact the data producer directly to discuss terms and conditions of access.</conditions></useStmt></dataAccs><othrStdyMat><relStdy>Immunological Profiling</relStdy><relStdy>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</relStdy></othrStdyMat></stdyDscr></codeBook>